Sunovion Pharmaceuticals Inc. announced the nationwide US availability of Zetonna (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of...
Sunovion has announced that it has entered into a definitive agreement to divest its US marketing rights to Sunovion's ciclesonide...
AstraZeneca has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group (Covis Pharma).